OFI Invest Asset Management Decreases Stock Holdings in HCA Healthcare, Inc. $HCA

OFI Invest Asset Management lessened its position in shares of HCA Healthcare, Inc. (NYSE:HCA) by 96.7% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 2,114 shares of the company’s stock after selling 61,712 shares during the quarter. OFI Invest Asset Management’s holdings in HCA Healthcare were worth $901,000 as of its most recent SEC filing.

A number of other institutional investors have also recently made changes to their positions in HCA. Abound Wealth Management increased its position in HCA Healthcare by 28.0% during the 3rd quarter. Abound Wealth Management now owns 119 shares of the company’s stock valued at $51,000 after buying an additional 26 shares in the last quarter. ORG Partners LLC increased its holdings in shares of HCA Healthcare by 27.9% during the second quarter. ORG Partners LLC now owns 142 shares of the company’s stock valued at $55,000 after acquiring an additional 31 shares in the last quarter. Glenview Trust co grew its position in HCA Healthcare by 2.3% during the 1st quarter. Glenview Trust co now owns 1,451 shares of the company’s stock worth $501,000 after purchasing an additional 32 shares during the last quarter. Sivia Capital Partners LLC lifted its stake in shares of HCA Healthcare by 5.5% during the second quarter. Sivia Capital Partners LLC now owns 630 shares of the company’s stock worth $241,000 after buying an additional 33 shares during the period. Finally, Claret Asset Management Corp increased its position in shares of HCA Healthcare by 5.9% in the 2nd quarter. Claret Asset Management Corp now owns 614 shares of the company’s stock valued at $235,000 after acquiring an additional 34 shares during the period. Institutional investors and hedge funds own 62.73% of the company’s stock.

HCA Healthcare Trading Up 0.4%

NYSE:HCA opened at $473.78 on Wednesday. The firm has a market cap of $108.11 billion, a P/E ratio of 18.31, a price-to-earnings-growth ratio of 1.39 and a beta of 1.36. The stock has a 50 day moving average of $472.46 and a two-hundred day moving average of $418.55. HCA Healthcare, Inc. has a 12 month low of $289.98 and a 12 month high of $520.00.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings results on Friday, October 24th. The company reported $6.96 EPS for the quarter, topping the consensus estimate of $5.64 by $1.32. HCA Healthcare had a negative return on equity of 792.25% and a net margin of 8.53%.The firm had revenue of $19.16 billion during the quarter, compared to analysts’ expectations of $18.55 billion. During the same period in the previous year, the business earned $4.90 earnings per share. The firm’s revenue for the quarter was up 9.6% on a year-over-year basis. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. On average, research analysts forecast that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, December 29th. Shareholders of record on Monday, December 15th will be issued a $0.72 dividend. The ex-dividend date is Monday, December 15th. This represents a $2.88 dividend on an annualized basis and a yield of 0.6%. HCA Healthcare’s dividend payout ratio is presently 11.13%.

Insider Buying and Selling at HCA Healthcare

In other news, EVP Michael R. Mcalevey sold 3,892 shares of the company’s stock in a transaction that occurred on Wednesday, November 5th. The stock was sold at an average price of $473.79, for a total value of $1,843,990.68. Following the completion of the sale, the executive vice president directly owned 3,487 shares in the company, valued at $1,652,105.73. This represents a 52.74% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 1.30% of the stock is currently owned by corporate insiders.

Analysts Set New Price Targets

A number of brokerages have recently weighed in on HCA. Barclays increased their price objective on HCA Healthcare from $445.00 to $494.00 and gave the company an “overweight” rating in a report on Monday, October 27th. Sanford C. Bernstein restated a “market perform” rating and set a $417.00 price objective on shares of HCA Healthcare in a research note on Monday, October 27th. Weiss Ratings reiterated a “buy (b)” rating on shares of HCA Healthcare in a research note on Monday. Morgan Stanley lowered shares of HCA Healthcare from an “equal weight” rating to an “underweight” rating and set a $425.00 price target on the stock. in a report on Monday, December 15th. Finally, Bank of America upped their target price on HCA Healthcare from $430.00 to $470.00 and gave the stock a “neutral” rating in a research note on Monday, October 27th. Fourteen investment analysts have rated the stock with a Buy rating, nine have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, HCA Healthcare has a consensus rating of “Moderate Buy” and an average price target of $479.00.

HCA Healthcare Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.